IDXG Interpace Biosciences, Inc.

OTC
$1.66

Interpace Biosciences, Inc. (IDXG) is expected to report earnings on November 9, 2026, after the market close.

Interpace Biosciences, Inc. Reported Earnings
Monday, August 10, 2026 · 4:35 PM ET
Earnings Date
Nov 9
Monday · 4:40 PM ET
Earnings Whisper
-
vs -
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP -

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Interpace Biosciences, Inc.

Interpace Biosciences Inc. is enabling personalized medicine, offering specialized services along the therapeutic value chain from early diagnosis and prognostic planning to targeted therapeutic applications. Its clinical services include molecular diagnostic tests, bioinformatics, and pathology services. Pharma services provide pharmacogenomics testing, genotyping, biorepository, and other customized services to the pharmaceutical and biotech industries. Interpace Biosciences Inc., formerly known as INTERPACE DIAGN, is based in PARSIPPANY, NJ.

Sector

Healthcare